Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice

Clinical trial NCT07505095 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07505095
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Alzheimer Disease (AD)Alzheimer Dementia MCI-AD, Early Stage Alzheimer's Disease

Start date: 2026-04-30
Primary completion: 2027-04-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.